Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.83B |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.52B |
| 3 |
UBS Group
UBS
|
+$1.11B |
| 4 |
Johnson & Johnson
JNJ
|
+$920M |
| 5 |
Bank of America
BAC
|
+$919M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.98B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.37B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$931M |
| 5 |
Coca-Cola
KO
|
+$880M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.77% |
| 2 | Financials | 15.86% |
| 3 | Technology | 14% |
| 4 | Consumer Discretionary | 10.34% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FGL
1801
DELISTED
Fidelity & Guaranty Life
FGL
| $15.7M | ﹤0.01% |
647,221
-149,397
| -19% | -$3.51M |
|
1802
Center Bancorp
CNOB
$1.81B
| $15.7M | ﹤0.01% |
824,400
+367,959
| +81% | +$6.82M |
|
|
DBD
1803
DELISTED
Diebold Nixdorf Incorporated
DBD
| $15.6M | ﹤0.01% |
451,500
+39,300
| +10% | +$1.39M |
|
1804
Enphase Energy
ENPH
$5.39B
| $15.6M | ﹤0.01% |
1,093,296
-128,373
| -11% | -$1.6M |
|
1805
Waterstone Financial
WSBF
$378M
| $15.6M | ﹤0.01% |
1,184,200
-36,390
| -3% | -$446K |
|
|
CLGX
1806
DELISTED
Corelogic, Inc.
CLGX
| $15.5M | ﹤0.01% |
491,658
-212,500
| -30% | -$6.48M |
|
1807
Fate Therapeutics
FATE
$294M
| $15.5M | ﹤0.01% |
3,084,373
+7,800
| +0.3% | +$34.4K |
|
|
ZOES
1808
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $15.4M | ﹤0.01% |
515,700
-624,317
| -55% | -$20.2M |
|
1809
CME Group
CME
$94.3B
| $15.4M | ﹤0.01% |
173,274
-24,061
| -12% | -$2.04M |
|
1810
Moelis & Co
MC
$4.91B
| $15.4M | ﹤0.01% |
439,500
+135,000
| +44% | +$4.46M |
|
|
HWCC
1811
DELISTED
Houston Wire & Cable Company
HWCC
| $15.3M | ﹤0.01% |
1,277,623
| – | – |
|
|
DCUB
1812
DELISTED
DOMINION RESOURCES INC CORP UNIT 2013 SER B (VA)
DCUB
| $15.2M | ﹤0.01% |
253,400
-282,700
| -53% | -$16.4M |
|
|
TESS
1813
DELISTED
Tessco Technologies Inc
TESS
| $15.2M | ﹤0.01% |
525,000
| – | – |
|
|
ZGNX
1814
DELISTED
Zogenix, Inc.
ZGNX
| $15.2M | ﹤0.01% |
1,386,212
| – | – |
|
|
CMLP
1815
DELISTED
CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE)
CMLP
| $15.2M | ﹤0.01% |
+1,000,000
| New | +$19.1M |
|
1816
Dare Bioscience
DARE
$20.5M
| $15.1M | ﹤0.01% |
20,262
| – | – |
|
1817
Designer Brands
DBI
$311M
| $15.1M | ﹤0.01% |
404,131
-1,245,900
| -76% | -$40.7M |
|
1818
Ituran Location and Control
ITRN
$1.07B
| $15M | ﹤0.01% |
682,093
| – | – |
|
1819
Citi Trends
CTRN
$617M
| $15M | ﹤0.01% |
593,400
+21,700
| +4% | +$496K |
|
1820
MakeMyTrip
MMYT
$5.67B
| $14.9M | ﹤0.01% |
574,200
-10,900
| -2% | -$298K |
|
1821
MaxLinear
MXL
$6.95B
| $14.9M | ﹤0.01% |
2,005,682
+394,379
| +24% | +$2.82M |
|
|
WINT
1822
DELISTED
Windtree Therapeutics Inc
WINT
| $14.8M | ﹤0.01% |
914,330
+1,402
| +0.2% | +$30.8K |
|
1823
GATX Corp
GATX
$6.34B
| $14.8M | ﹤0.01% |
256,726
-419,806
| -62% | -$25M |
|
|
ORBK
1824
DELISTED
Orbotech Ltd
ORBK
| $14.8M | ﹤0.01% |
998,100
| – | – |
|
1825
Emergent Biosolutions
EBS
$230M
| $14.7M | ﹤0.01% |
541,441
-30,300
| -5% | -$722K |
|
Similar funds
Fidelity Investments's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity Investments held 2,940 positions worth $769B, up 4.1% from $738B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Fidelity Investments's Q4 2014 filing shows 176 new, 1,100 increased, 1,140 reduced and 160 closed positions. Its largest new stake was UBS Group: 64,914,641 shares worth $1.11B. The largest sale was AbbVie, an estimated $2.98B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
- Fidelity Investments's largest Q4 2014 buy was UBS Group: 64,914,641 shares worth $1.11B.
- Fidelity Investments added most to Medtronic in Q4 2014, an estimated $1.83B increase.
- Fidelity Investments's biggest Q4 2014 reduction was AbbVie, cutting an estimated $2.98B.
- Fidelity Investments fully exited TIM HORTONS INC COM, CANADA in Q4 2014, selling an estimated $693M.
- Fidelity Investments's ten largest holdings make up 14% of its $769B portfolio in Q4 2014.
- Fidelity Investments opened 176 new positions and closed 160 in Q4 2014.
- Fidelity Investments's portfolio value rose 4.1% quarter-over-quarter to $769B.
Based on Fidelity Investments's 13F filing for Q4 2014, filed 17 Feb 2015.